Identification of Dopamine D1–D3 Receptor Heteromers
Daniel Marcellino(Umeå University), Rafael Franco(Instituto de Salud Carlos III), Vicent Casadó(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer), Aroa Soriano(Vall d'Hebron Institut de Recerca), Carmen Mazzola(University of Catania), Kjell Fuxé(Karolinska Institutet), Oliver Saur(Goethe University Frankfurt), Filippo Drago(University of Catania), Bernard Le Foll(Centre for Addiction and Mental Health), Chanel Barnes(National Institute on Drug Abuse), Holger Stark(Goethe University Frankfurt), Antonio Cortés(Universitat de Barcelona), Sergi Ferré(National Institutes of Health), Steven R. Goldberg(National Institute on Drug Abuse), Carme Lluı́s(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer)
Cited by 230
Related Papers
International Union of Basic and Clinical Pharmacology. XCVIII. Histamine Receptors
|Pharmacological Reviews|2015|558
Polypharmacology by Design: A Medicinal Chemist’s Perspective on Multitargeting Compounds
|Journal of Medicinal Chemistry|2018|476
Attenuation of levodopa-induced dyskinesia by normalizing dopamine D3 receptor function
|Nature Medicine|2003|381
Tobacco and nicotine use
|Nature Reviews Disease Primers|2022|293
DOGS: Reaction-Driven de novo Design of Bioactive Compounds
|PLoS Computational Biology|2012|264